- Home
- COCH vs ALGS Comparison
COCH vs ALGS Comparison
Compare COCH & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- ALGS
- Stock Information
- Founded
- COCH 1995
- ALGS 2018
- Country
- COCH United States
- ALGS United States
- Employees
- COCH N/A
- ALGS N/A
- Industry
- COCH Blank Checks
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- ALGS Health Care
- Exchange
- COCH Nasdaq
- ALGS Nasdaq
- Market Cap
- COCH 31.6M
- ALGS 36.0M
- IPO Year
- COCH N/A
- ALGS 2020
- Fundamental
- Price
- COCH $1.48
- ALGS $7.21
- Analyst Decision
- COCH Strong Buy
- ALGS Strong Buy
- Analyst Count
- COCH 2
- ALGS 1
- Target Price
- COCH $9.25
- ALGS $70.00
- AVG Volume (30 Days)
- COCH 19.7K
- ALGS 134.1K
- Earning Date
- COCH 08-11-2025
- ALGS 08-05-2025
- Dividend Yield
- COCH N/A
- ALGS N/A
- EPS Growth
- COCH N/A
- ALGS N/A
- EPS
- COCH N/A
- ALGS N/A
- Revenue
- COCH $212,000.00
- ALGS $3,270,000.00
- Revenue This Year
- COCH $8.04
- ALGS N/A
- Revenue Next Year
- COCH $15.39
- ALGS $51.55
- P/E Ratio
- COCH N/A
- ALGS N/A
- Revenue Growth
- COCH N/A
- ALGS N/A
- 52 Week Low
- COCH $1.21
- ALGS $3.76
- 52 Week High
- COCH $3.99
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- COCH 51.56
- ALGS 51.55
- Support Level
- COCH $1.36
- ALGS $7.11
- Resistance Level
- COCH $1.47
- ALGS $8.66
- Average True Range (ATR)
- COCH 0.10
- ALGS 0.83
- MACD
- COCH 0.00
- ALGS -0.05
- Stochastic Oscillator
- COCH 47.45
- ALGS 18.59
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.